Page last updated: 2024-10-23

bisindolylmaleimide i and Immunologic Deficiency Syndromes

bisindolylmaleimide i has been researched along with Immunologic Deficiency Syndromes in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glassford, J1
Soeiro, I1
Skarell, SM1
Banerji, L1
Holman, M1
Klaus, GG1
Kadowaki, T1
Koyasu, S1
Lam, EW1

Other Studies

1 other study available for bisindolylmaleimide i and Immunologic Deficiency Syndromes

ArticleYear
BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Oncogene, 2003, Apr-17, Volume: 22, Issue:15

    Topics: Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Antibodi

2003